Medications for Opioid Use Disorder (MOUD): A Whole-Patient Approach to Recovery

At BHG, we understand that effective treatment for opioid use disorder (OUD) requires more than medication alone. Our approach to medications for opioid use disorder combines FDA-approved with counseling and coordinated wraparound services to support long-term recovery and improved patient outcomes.

We offer all three FDA-approved medications – methadone, buprenorphine and naltrexone – allowing our medical teams to individualize care based on each patient’s clinical profile, treatment history, co-occurring conditions and recovery goals. This flexibility enables us to meet patients where they are and adjust treatment as needs evolve.

A key component of successful MOUD care is dose stabilization. Achieving the appropriate dose under experienced medical supervision helps reduce withdrawal symptoms, minimize cravings, and restore daily functioning. Stabilization allows patients to re-engage with work, family, and counseling while remaining actively involved in treatment.

Our model integrates medical management with:

• Evidence-based counseling approaches
• Case management support
• Peer and recovery services
• Ongoing monitoring and care coordination

This whole-patient framework strengthens treatment retention and supports long-term stability.

A Streamlined Referral Experience

We know timely access to care matters. BHG offers a simplified referral process designed to reduce barriers and accelerate patient engagement. Referring partners can access our dedicated referral line 24/7 or securely submit referrals online. Same-day or next-day intake and medication initiation are available across locations.

Our goal is to serve as a reliable extension of your care team – providing safe, evidence-based treatment while maintaining open communication and collaboration.

If you are seeking a trusted partner for medications for opioid use disorder, BHG is here to help patients stabilize, engage and move forward in recovery.